72.11.Z - Research and experimental development on biotechnology
32.50.Z - Manufacture of medical and dental instruments and supplies
62.01.Z - Computer programming activities
62.09.Z - Other information technology and computer service activities
63.12.Z - Web portals
71.20.B - Other technical testing and analysis
72.19.Z - Other research and experimental development on natural sciences and engineering
74.90.Z - Other professional, scientific and technical activities not elsewhere classified
85.60.Z - Educational support activities
86.90.E - Other human health activities notelsewhere classified
2021 | 2022 | 2023 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Gross profit (loss) | -12,2 | -5,6 | 9,2 | 264,2 |
EBITDA | -12,1 | -5,5 | 11,8 | 312,6 |
Short time liabilities | 0,9 | 1,7 | 106,2 | 6244,5 |
Equity capital | 25,8 | 20,2 | 21,8 | 8 |
Operating profit (EBIT) | -12,1 | -5,5 | 11,8 | 312,6 |
Assets | 26,7 | 21,9 | 128 | 484,8 |
Net profit (loss) | -12,2 | -5,6 | 1,6 | 129 |
Cash | 24,5 | 19 | 118,1 | 521,1 |
Net income from sale | -1,1 | 9 | 108,4 | 1097,8 |
Liabilities and provisions for liabilities | 0,9 | 1,7 | 106,2 | 6244,5 |
Working assets | 25,7 | 20,9 | 127 | 508 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | -47,2 | -27,7 | 7,4 | 35,1 |
Equity capital to total assets | 96,8 | 92,4 | 17,1 | -75,3 |
Gross profit margin | -61,9 | 8,5 | 70,4 | |
EBITDA Margin | 1122,5 | -61,1 | 10,9 | 72 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | -288 | 67 | 358 | 291 |
Current financial liquidity indicator | 30.128602981567383 | 12.48173713684082 | 1.1962448358535767 | -11,3 |
Net dept to EBITDA | 2.024608850479126 | 3.4358396530151367 | -9.718077659606934 | -13,1 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane